Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplasma phagocytophilum infection

AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplasma phagocytophilum infection

US Patent 10842860 · Granted Nov 24, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric vaccine antigens for anaplasmosis2025
AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplas2022
Chimeric vaccine antigens for anaplasmosis2022
OmpA and Asp14 in vaccine compositions and as diagnostic targets2020
OmpA in vaccine compositions and as diagnostic targets2019
OmpA and ASP14 in vaccine compositions and as diagnostic targets2019
AIPA, OMPA, and ASP14 in vaccine compositions and diagnostic targets for anaplas2018
OmpA and Asp14 in vaccine compositions and as diagnostic targets2018
OmpA in vaccine compositions and as diagnostic targets2018
OMPA and ASP14 in vaccine compositions and as diagnostic targets2016